all report title image

NEUROPROTECTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Neuroprotection Market, By Product Type (Pharmaceuticals, Biologics, Nutraceuticals, and Others), By Mechanism of Action (Antioxidants, Anti-inflammatory Drugs, Neurotransmitter Modulators, Calcium Channel Blockers, NMDA Receptor Antagonists, and Others), By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Huntington’s Disease, Traumatic Brain Injury (TBI), Ischemic Stroke, Epilepsy, Retinal Degeneration, Glaucoma, Spinal Cord Injuries, and Others), By Patient Demographics (Pediatric Patients, Adult Patients, and Geriatric Patients), By Gender Male and Female), By Route of Administration (Oral, Injectable, Intranasal, Transdermal, and Sublingual), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

  • Published In: 31 Mar, 2026
  • Code: CMI8015
  • Page number: 135
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Neuroprotection Market, By Product Type
      • Global Neuroprotection Market, By Mechanism of Action
      • Global Neuroprotection Market, By Application
      • Global Neuroprotection Market, By Patient Demographics
      • Global Neuroprotection Market, By Gender
      • Global Neuroprotection Market, By Route of Administration
      • Global Neuroprotection Market, By Distribution Channel
      • Global Neuroprotection Market, By Region
  3. Market Dynamics, Regulations, And Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Neuroprotection Market, By Product Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pharmaceuticals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Biologics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Nutraceuticals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Neuroprotection Market, By Mechanism of Action, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Antioxidants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Anti-inflammatory Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Neurotransmitter Modulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Calcium Channel Blockers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • NMDA Receptor Antagonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Neuroprotection Market, By Application, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Alzheimer’s Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Parkinson’s Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Multiple Sclerosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Amyotrophic Lateral Sclerosis (ALS)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Huntington’s Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Traumatic Brain Injury (TBI)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ischemic Stroke
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Epilepsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retinal Degeneration
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Glaucoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Spinal Cord Injuries
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Neuroprotection Market, By Patient Demographics, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Adult Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Geriatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Neuroprotection Market, By Gender, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Male
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Female
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Neuroprotection Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Intranasal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Transdermal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Sublingual
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Neuroprotection Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  11. Global Neuroprotection Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Mechanism of Action, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Patient Demographics, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape

    • Biogen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Roche Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GSK (GlaxoSmithKline)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • UCB S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Neuroprotection Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.